Benefits
Prostate & Urinary Comfort
Multiple trials report nettle root supports prostate comfort and urinary flow (studied in men with BPH) versus placebo. Often combined with saw palmetto (Prostagutt forte® / pro 160/120 — 160 mg saw palmetto + 120 mg nettle root) — major European phytotherapy product.
SHBG Binding (Free Testosterone Theoretical)
Nettle root lignans bind to sex hormone-binding globulin (SHBG) — theoretically displacing testosterone and increasing free (active) testosterone. Mechanism cited for testosterone-supportive marketing. Clinical translation modest.
5-Alpha-Reductase Inhibition (Modest)
Laboratory studies suggest nettle root may modestly inhibit 5-alpha-reductase (the enzyme that forms DHT), though human confirmation is limited. Component of mechanism for BPH benefits.
Aromatase Inhibition (Modest)
Laboratory (in vitro) studies suggest modest aromatase inhibition — reducing testosterone-to-estrogen conversion — but whether this occurs at supplement doses in humans is unproven.
Urinary Symptom Improvement
Beyond BPH, may help functional urinary symptoms — frequency, urgency, nocturia. Used in some traditions for general urinary support.
Mechanism of action
SHBG Binding
Nettle root lignans bind SHBG with significant affinity in vitro — theoretically displacing testosterone and increasing free testosterone. In vivo significance debated; protein binding alterations have complex pharmacokinetic effects.
5-Alpha-Reductase Modulation
Laboratory evidence suggests modest 5-alpha-reductase modulation, which may lower DHT formation; this is one proposed mechanism for its prostate-comfort effects, though its clinical contribution in humans is not established.
Anti-Inflammatory in Prostate Tissue
Reduces inflammation in prostatic tissue — relevant for BPH (which has inflammatory component) and chronic prostatitis.
UDA Lectin Effects
Urtica dioica agglutinin (UDA) is a lectin with multiple cellular effects including immune modulation. Significance in supplementation context unclear.
Clinical trials
Clinical trial of nettle root + saw palmetto combination (pro 160/120) vs placebo in 257 BPH patients for 24 weeks.
257 BPH patients.
Significant improvement in IPSS (International Prostate Symptom Score), urinary flow, residual urine vs placebo. Combined product limits attribution to nettle root alone. One positive placebo-controlled combination trial; because it combines saw palmetto and nettle root, the contribution of nettle root alone cannot be isolated.
Clinical trial of nettle root extract alone vs placebo in 620 BPH patients for 6 months.
620 BPH patients.
Significant improvement in BPH symptoms, urinary flow, post-void residual vs placebo. Supports standalone nettle root for urinary symptoms in this single trial, pending independent replication.